Riskpilot← Back to searchSign inGet full accessMSTOTA-allmed AB
ABActiveOrg 5591520068Ottevägen 97General medical practice activities · NACE 8621Est. 20181 employees
Revenue 2025
SEK 998K
-99812700% vs 2024
EBITDA margin
68.2%
+2380% vs 2024
Equity ratio
65.2%
Financial strength
Net profit 2025
SEK 532K
+2639% vs 2024
| Revenue | SEK 998K | -99812700% |
| EBITDA | SEK 680K | +2380% |
| Net profit | SEK 532K | +2639% |
| Total assets | SEK 1,2M | +64% |
| Equity | SEK 765K | +12% |
| Employees | 1 | — |
Legal name
MSTOTA-allmed AB
Org number
5591520068
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
12 mars 2018
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Hyrläkarverksamhet.
Address
Ottevägen 97
Email
mohammed.asm.saliem@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 561 | 510 | 1 001 | −0 | 998 |
| Staff expenses | — | −373 | −280 | 95 | −203 |
| EBITDA | 105 | 41 | 543 | 27 | 680 |
| Depreciation & amort. | −0 | — | — | −3 | −10 |
| EBIT | 105 | 41 | 543 | 24 | 671 |
| Net financials | — | −0 | 1 | 0 | −1 |
| Profit before tax | 105 | 40 | 543 | 24 | 670 |
| Tax | −22 | −8 | −112 | −5 | −138 |
| Net profit | 83 | 32 | 431 | 19 | 532 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 686 | 589 | 855 | 718 | 1 174 |
| Equity | 441 | 473 | 664 | 684 | 765 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 245 | 116 | 191 | 34 | 408 |
| Total debt | 245 | 116 | 191 | 34 | 408 |
EBITDA margin
68.2%
This company
15.8%
Market median
+332% vs market
20212025
Equity ratio
65.2%
This company
38.2%
Market median
+71% vs market
20212025
Return on equity
69.5%
This company
18.4%
Market median
+278% vs market
20212025
Net profit margin
53.3%
This company
8.1%
Market median
+558% vs market
20212025
Asset turnover
0.85×
This company
1.12×
Market median
+24% vs market
20212025
Debt / equity
0.53×
This company
0.62×
Market median
+15% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MSTOTA-allmed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mohammed Abdelsalam Mohammed Saliem | Board of Directors | 0 companies |
| Samah El Sayed Ahmed Mohammed Ads | Deputy Board Member | 0 companies |
| Tasbeeh Mohammed Saliem | Chairman | 0 companies |